Global cardiometabolic monitoring products market - 2024-2031

Global cardiometabolic monitoring products market - 2024-2031

Global Cardiometabolic Monitoring Products Market reached US$ YY million in 2023 and is expected to reach US$ YY million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031

Cardiometabolic monitoring products are essential tools for tracking and managing health parameters related to cardiovascular and metabolic systems, such as heart disease, diabetes, hypertension, and obesity, which are often interconnected and collectively known as cardiometabolic diseases.

Market Dynamics: Drivers & Restraints

Rise in the prevalence of cardiovascular diseases

Cardiometabolic disorders (CMDs) are the leading cause of death worldwide. Cardiovascular disease (CVD), diabetes mellitus, and chronic renal failure are examples. CMDs are mostly caused by an unhealthy lifestyle, with physical inactivity, smoking, and an improper diet being key risk factors.

For instance, according to WHO, cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year. More than four out of five CVD deaths are due to heart attacks and strokes, and one-third of these deaths occur prematurely in people under 70 years of age.



High cost of devices



Advanced cardiometabolic monitoring devices, like continuous glucose monitors and multi-parameter monitors, can be costly for healthcare providers and patients due to their high initial investment and ongoing expenses for consumables like test strips and sensors. Moreover, factors like, regulatory and compliance issue, limited reimbursement policies, data privacy and security conerns and among others hinder the market during the forecast period.



For more details on this report – Request for Sample

Segment Analysis

The global cardiometabolic monitoring products market is segmented based on product type, indication, end-user and region.

The blood glucose monitors from the product type segment accounted for approximately 37.3% of the cardiometabolic monitoring products market share

The blood glucose monitors from the product type segment accounted for approximately 37.3%. Blood glucose monitors are a critical component of cardiometabolic monitoring products, playing a vital role in the management of diabetes and related metabolic disorders. These devices measure the concentration of glucose in the blood, providing essential information for the management of diabetes and helping to prevent complications associated with both high and low blood sugar levels.

For instance, in June 2024, Prevounce Health launched Pylo GL1-LTE, a cellular-connected remote blood glucose meter for remote monitoring of patients. This new clinically validated device is designed to enhance remote patient monitoring (RPM) programmes for diabetes management by ensuring reliable data transmission across the US.

Geographical Analysis

North America is estimated to hold about 38.4% of the total market share throughout the forecast period

North America is estimated to hold about 38.4% of the total market share throughout the forecast period owing to factors like the novel product launches, FDA approvals, collaborations, advanced healthcare infrastructure in the region and other factors help the region to grow during the forecast period.

For instance, in February 2024, Neomorph announced Multi-Target Collaboration with Novo Nordisk to Discover Novel Molecular Glue Degraders for Cardiometa Under the terms of the agreement, Neomorph will receive an upfront and near-term milestone payments, plus R&D funding. Neomorph is also eligible to receive future clinical, commercial and sales milestone payments bringing the total potential deal value for multiple targets to $1.46B, plus tiered royalties.

Covid 19 Impact Analysis

The COVID-19 pandemic has worsened cardiometabolic health at the population level due to factors like reduced physical activity, poor diet, and increased stress, increasing the risk of cardiometabolic diseases. The strain on healthcare systems disrupted routine monitoring and management of cardiometabolic conditions, potentially impacting population health.

Market Segmentation

By Product Type
• Blood Glucose Monitors
• Blood Pressure Monitors
• POC Analysers
• Cholesterol Analyser
• Holter monitor
• ECG
• Others

By Indication
• Cardiovascular Diseases
• Metabolic Disorders
• Others

By End-User
• Hospitals
• Diagnostic Centers
• Ambulatory Surgical Centers
• Others

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
UK
France
Italy
Spain
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape

The major global players in the market include Abbott Laboratories, Medtronic Plc, Jana Care, Johnson & Johnson, GE Healthcare, Omron Healthcare, Philips Healthcare, Dexcom, Roche Diagnostics, Bayer AG among others.

Key Developments

 In May 2024, Beurer India Pvt. Ltd, the manufacturer of electric healthtech devices, announced the launch of a blood glucose monitor device retailing for ₹1,200, which will be available in the market by September 2024.

 In October 2023, Better Therapeutics, Inc., a pioneer in developing prescription digital therapeutics (PDTs) to treat cardiometabolic diseases, announced the commercial launch of AspyreRx, the first cognitive behavioural therapy (CBT) app to receive U.S Food and Drug Administration (FDA) authorization as a Class II device to treat adults with type 2 diabetes (T2D).

Why Purchase the Report??
• To visualize the global cardiometabolic monitoring products market segmentation based on product type, indication, end user and region as well as understand key commercial assets and players.
• identify commercial opportunities by analyzing trends and co-development.
• excel data sheet with numerous data points of the cardiometabolic monitoring products market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global cardiometabolic monitoring products market report would provide approximately 64 tables, 61 figures and 186 pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies